“What if we could harness the electrical activity within our biological systems to redefine healthcare?”
— Samir S. Awad, MD, Medical Director, Electrome
Introduction
Electrome is pioneering the future of medicine by decoding and harnessing the electrical signals that underlie biological function. Across cell biology, engineering, clinical research, and artificial intelligence, discoveries about endogenous bioelectricity are being translated into therapies that promise to transform regenerative medicine, pain care, oncology, and much more (1,2,3,4).
Mapping the electrome: the scientific shift
Modern biology is shifting from a strictly chemical and genetic model to one that recognizes the profound influence of electric fields, voltage gradients, and ion channel signaling (1). Every living cell—from neurons to stem cells controls its membrane potential through the regulated flow of ions, creating electrical microenvironments that guide growth, repair, and communication (2). This “electrome” can now be mapped and modulated with precision using advanced imaging, biosensors, and AI-powered analytics.
Electrome employs voltage-sensitive dyes, biosensors, and high-density computational platforms to create real-time electrical atlases of tissues, organs, and whole systems (2,3). These platforms not only expand basic science but also yield actionable clinical protocols designed to adjust bioelectric signals for optimal healing and function.
Healing and regeneration: turning electrical insights into outcomes
Tissue repair is tightly governed by bioelectric signaling (1). After injury, endogenous electrical fields direct stem cell migration, immune activation, and tissue restoration (1). Research shows that applied stimulation accelerates wound closure, reduces scarring, and restores nerve function in difficult cases (2). Electrome has advanced these findings into personalized regenerative protocols validated in multi-center studies, with outcomes including faster healing, lower infection rates, and improved long-term tissue function (2,3).
Engineering and clinical integration
Next-generation therapies demand seamless integration between engineering and clinical practice. Electrome’s teams collaborate to design smart wearables and hydrogel patches that sense and adjust bioelectric activity in real time (2). Closed-loop feedback, AI-driven stimulation algorithms, and secure health data integration make these devices adaptable to hospital, clinic, or home environments.
Bioelectric modulation in pain management
Pain is fundamentally an electrical phenomenon, carried through nerve impulses and central circuits (3). Neuromodulation therapies such as transcutaneous electrical stimulation, spinal cord stimulation, and targeted peripheral techniques have already proven effective at disrupting chronic pain pathways (4). Electrome is advancing the field by embedding biosignal analytics, motion sensors, and machine learning into its devices (2). Studies confirm reduced pain scores, improved mobility, and reduced dependence on opioids and other pharmaceuticals (4).
Cancer: electric profiling and tumor treatment
Cancer cells exhibit altered membrane potentials, dysregulated ion channels, and disrupted electrical signaling (5). These changes drive proliferation and therapy resistance (5). Electrome is collaborating with oncology networks to integrate electric profiling into cancer care. Efforts include identifying electric biomarkers, developing tumor-targeting field therapies, and enhancing chemotherapy effectiveness through electric sensitization (5,6).
Voices of Electrome
CTO Erik Nilsen emphasizes the engineering challenge and opportunity:
“We are developing technologies that provide precise control over electric signaling in cells, offering new opportunities to treat chronic pain, inflammation, and other debilitating conditions.”
Economic and social impact
Bioelectric medicine could dramatically reduce healthcare costs. Chronic pain, infections, and wounds account for a large share of global expenditures (7). Electrome’s solutions, designed for remote and outpatient use, reduce hospital stays, expand access, and support digital health engagement. Market forecasts project the bioelectric medicine sector will surpass $40 billion by 2032, with Electrome poised as a category leader (7,8).
Scientific leadership and innovation pipeline
Electrome’s strength lies in its integration of data-driven analytics, clinical feedback, and agile device development (2,3). Partnerships with academic centers and regulators accelerate translation, while open data initiatives expand access to underserved regions. Future goals include expanded clinical research into neurodegeneration, autoimmunity, and metabolic disease; smaller AI-enabled wearable platforms; a global electric profile database; and continued leadership in value-based and equitable care.
The path forward
As medicine enters an era of precision therapies, Electrome is committed to rigorous science and rapid translation (2,3). Upcoming device launches, enhanced AI models, and expanded advocacy will help establish bioelectric therapy as a standard of care for millions worldwide.
References
- Levin M. Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer. Cell. 2021;184(8):1971-1989. https://doi.org/10.1016/j.cell.2021.02.034
- Next-Generation Bioelectric Medicine: Harnessing the Therapeutic Potential. Front Neurol. 2020;11:616529. https://pmc.ncbi.nlm.nih.gov/articles/PMC8370382/
- Bioelectronic medicine: preclinical insights and clinical advances. Nat Neurosci. 2022;25(11):1375-1383. https://pmc.ncbi.nlm.nih.gov/articles/PMC10155266/
- 8 Companies Developing Bioelectronic Devices. Nanalyze. https://www.nanalyze.com/2021/03/fda-approved-bioelectronic-devices/
- Bioelectronic medicines: Therapeutic potential and advancements in next-generation cancer therapy. J Control Release. 2022;349:440-456. https://www.sciencedirect.com/science/article/abs/pii/S0304419X22001330
- Experts Forecast Cancer Research and Treatment Advances in 2025. AACR. 2025. https://www.aacr.org/blog/2025/01/10/experts-forecast-cancer-research-and-treatment-advances-in-2025/
- Electroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion Globally by 2032. Allied Market Research. 2024. https://www.prnewswire.com/news-releases/electroceuticalsbioelectric-medicine-market-to-reach-40-5-billion-globally-by-2032-at-7-4-cagr-allied-market-research-302124096.html
- Grand View Research. Bioelectric Medicine Market Size and Share Report, 2030. https://www.grandviewresearch.com/industry-analysis/bioelectric-medicine-market
What Comes Next: Consciousness, Cognition & Electric Identity
In Bioelectric Science, Vol. VI, we will explore how bioelectricity shapes not only healing and disease, but consciousness itself. Can electrical modulation enhance cognition, memory, or perception? What ethical questions emerge as we learn to write and rewrite the electric code of human identity?
Bioelectric Science Series Recap
Vol. I: The Future is Electric
Vol. II: The Signal Effect
Vol. III: Electric Immunity
Vol. IV: The Personalized Pulse
Vol. V: The Electric Brain
Vol. VI: The Electric Code: Rewriting Biology’s Operating System
Vol. VII: Signals of the Self — Bioelectricity, Consciousness, and Human Enhancement
Electrome: Bioelectric Science Series is published by Electrome Corporation as a frontier journal and cultural signal for the emerging field of frequency-based medicine. To collaborate, invest, or license, visit www.electrome.com.